Skip to main content

and
  1. Article

    Open Access

    Pre-clinical evaluation of the efficacy and safety of human induced pluripotent stem cell-derived cardiomyocyte patch

    Cell- or tissue-based regenerative therapy is an attractive approach to treat heart failure. A tissue patch that can safely and effectively repair damaged heart muscle would greatly improve outcomes for patien...

    Shigeru Miyagawa, Takuji Kawamura, Emiko Ito, Maki Takeda in Stem Cell Research & Therapy (2024)

  2. Article

    Open Access

    Rapid and sensitive mycoplasma detection system using image-based deep learning

    A major concern in the clinical application of cell therapy is the manufacturing cost of cell products, which mainly depends on quality control. The mycoplasma test, an important biological test in cell therap...

    Hiroko Iseoka, Masao Sasai, Shigeru Miyagawa in Journal of Artificial Organs (2022)

  3. Article

    Open Access

    Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model

    Transplantation of skeletal myoblast sheets is a promising strategy for the treatment of heart failure, and its therapeutic effects have already been proven in both animal disease models and clinical trials. M...

    Hiroko Iseoka, Shigeru Miyagawa, Atsuhiro Saito in Stem Cell Research & Therapy (2020)

  4. Article

    Open Access

    Tumorigenicity assay essential for facilitating safety studies of hiPSC-derived cardiomyocytes for clinical application

    Transplantation of cardiomyocytes (CMs) derived from human induced pluripotent stem cells (hiPSC-CMs) is a promising treatment for heart failure, but residual undifferentiated hiPSCs and malignant transformed ...

    Emiko Ito, Shigeru Miyagawa, Maki Takeda, Ai Kawamura, Akima Harada in Scientific Reports (2019)